Independent studies from three laboratories have shown that 0-2 filtrates of intestinal homogenates from patients with Crohn's disease cause transmissible cytopathic effects when inoculated into a variety of low passage fibroblast-like cell cultures. -3 The frequency of this in vitro abnormality using Crohn's disease intestine (80-90%) is significantly higher than that seen using disease control intestinal preparations (25%).3
Early studies of the properties of this cytopathic effect suggested that it was produced by an RNAvirus. l-3 More recent work by Phillpotts et al., however, has questioned these findings4 and subsequently indicated that a soluble toxin(s) may be responsible for the in vitro cytopathic effect.5 6 In the present studies, we have used an immunological approach in attempting to clarify further the nature of the cytopathic effects induced by Crohn's disease tissue filtrate (CD-TF) in cell culture. We hypothesised that if these effects were viral in nature, viral antigens would be expressed in such cultures and host immune reactivity to these antigens should be demonstrable.
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Methods

PATIENTS
Venous blood was obtained from 10 patients with Crohn's disease (six women, four men) with a mean age 35 years (20-63 years) and 10 healthy adults (five women, five men) with a mean age of 29 years (23-39 years). Among the patients with Crohn's disease six had ileitis, two had ileocolitis, and two had colitis. Eight of the 10 patients had had the disease for more than five years. At the time of blood sampling four patients had active disease, five inactive, and one post-ileal resection two days before. Five patients were taking no drugs at the time of study. The remaining five patients were receiving sulphasalazine (one), sulphasalazine and prednisone (one), or prednisone (three). Serum was separated from an aliquot of the venous sample and stored at -70°C. The remainder of the sample was heparinised and used for lymphoid cell isolation. CROHN . Additional experiments were carried out using cell culture extracts as potential lymphocyte stimulants as described for human herpes virus infectiori.12 13 After the cytopathic effect was manifested, the monolayer was scraped off with a rubber policeman into 0.5 ml Hanks balanced salt solution12 or 0.043M glycine buffered saline13 and then subjected to freeze-thawing. Supernatants were collected after centrifugation at 600 g for 10 minutes. As a negative control, extracts of uninoculated monolayers were prepared in the same manner. Fifty microlitres of the supernatant were added to 2-2x 105 peripheral blood lymphocytes in 150 gl RPMI 164090FCS1oPS in round bottom wells. After six days' incubation, the lymphocytes were pulsed with [3H]-thymidine and harvested as described for glutaraldehyde fixed monolayers.
LYMPHOCYTE-MEDIATED CYTOTOXICITY
Chick embryo cell monolayers grown in flat bottom microtitre wells-either uninoculated or inoculated with the Crohn's disease intestinal filtrate preparation-were incubated with medium containing 0.5 ,uCi of [51Cr] Na2 CrO4 (50-400 m Ci/mg Cr; Amersham Corp., Arlington Heights, Ill) for six hours, then washed three times with Eagle's minimal essential medium. 1 x 106 peripheral blood lymphocytes in 200 ,ul RPMI90FCSloPS were added to each well, and, after 16 hours' incubation, a 100,u aliquot was carefully taken into a tube from each well without disturbing the monolayer in the bottom and replaced with 100 ,ul of diluted (1:10) Zaponin solution (Coulter Diagnostics Inc., Hialeah, Fla) to lyse the target cells. After 596±135  6396±267  391±78  367±77  IN  CD  443±90  25080±1575  466±141  387±24  MG  CD  2111±94  33774±717  1390±141  2034±149  MN  CD  1547±40  44375±3767  1482±277  1597±328  AG  CD  763±62  26168±2319   999±51  1235±31  FR  CD  323±51  21342±613  353±9   361±38  CB  CD  604±126  21247±4709  1269±122  1570±194  WM  CD  1024±52  28190±868  954±46  1420±11  JS  CD  1173±89  23230±1709  903±265  1174±90  JE  Control  2304±331  14274±2276  2225±267  2721±322 Glutaraldehyde-fixed cell monolayers displaying cytotoxicity after inoculation with mumps, vaccinia, and measles viruses have been shown to elicit lymphocyte transformation, using peripheral blood lymphoid cells from subjects previously sensitised to these viruses.'1 In the present study we have confirmed this finding using mumps virus infected fixed cell monolayers. Using identical cell monolayers undergoing cytopathic effect in response to inoculation with Crohn's disease intestinal filtrates, however, no transformation of lymphoid cells from patients with Crohn's disease or healthy controls was observed (Table 1) .
We also attempted to elicit lymphocyte transformation in suspension using the Crohn's disease intestinal filtrate and cell extracts from cultures undergoing cytopathic effect after inoculation with this filtrate. The use of these extracts was predicted on evidence indicating that cell membraneassociated viral antigens are of key importance in the production of in vitro lymphocyte transformation. ' (Tables 2, 3) .
The in vivo significance of in vitro lymphocytemediated cytotoxicity against virus infected target cells remains uncertain. Nevertheless, this in vitro assay has been shown to reflect lymphocyte (T-cell, N-K cell, or both) reactivity in several established viral infections in man.'4 16 17 Using peripheral blood lymphoid cells from subjects exposed to measles, we have confirmed the presence of enhanced cytotoxicity against cell cultures infected with measles virus. By contrast, using these cells from control subjects or patients with Crohn's disease in a similar assay system incorporating cell cultures inoculated with Crohn's disease intestinal filtrates, no enhanced cytotoxicity was demonstrable ( Table 4) . As these experiments used xenogeneic target cells, the major function measured by these assays was probably that of N-K activity, rather than T-cell cytotoxicity.
Our previous attempts to detect antibody to the putative viral agents in Crohn's disease necessitated serum neutralisation of the cytopathic effect.3 These studies showed inhibition only at low serum dilutions, and no differences were observed between sera from patients with Crohn's disease and normal sera. 3 The present results using immunofluorescence also indicate the absence of apparent antibody activity in sera from patients with Crohn's disease or normal sera towards antigens expressed in cell cultures undergoing the cytopathic effect after inoculation with Crohn's disease intestinal filtrates. These findings are in agreement with those recently reported by Phillpotts et al.5 6 Thus, using established methods for detecting cellular and humoral immunity to known cytopathic viruses in culture, we have been able to show such reactivity to the proposed agents associated with Crohn's disease previously implicated in causing in vitro cytopathic effects. The number of donors studied (10 with Crohn's disease, 10 controls) was not large, but the consistency of the findings makes subject selection an unlikely explanation for the negative results. Could the findings be attributable to a more generalised depression of cellular immune function in Crohn's disease? Previous studies of cellular immunity in Crohn's disease have been in sharp conflict with regard to the presence or absence of T-cell deficiencyl8 Moreover, in the present study there was no significant difference in PHA responses between control or Crohn's disease PBL. Recently, N-K activity has been reported to be reduced in Crohn's disease,19 and possibly our negative findings using cytotoxicity could reflect deficient N-K function. This possibility would not, however, explain the negative results obtained using transformation assays.
In conclusion, we suggest that the results of the present study raise considerable doubt about the proposed viral causation of the in vitro cytopathic effect induced by Crohn's disease tissue filtrates. Very recent studies by Phillpotts et al.5 6 and McLaren et al.20 also provide evidence against this proposal. These workers have shown that many of the properties of the cytotoxicity induced by these filtrates are more consistent with a tissue associated toxic effect. Indeed, the inhibitory effect of Crohn's disease tissue filtrates on lymphocyte function observed in the present study may also represent such a toxic effect. 
